However, a recent analysis involving more than 20,000 patients after PCI tested uniformly-defined cutoff values for three relatively well-standardized assays (MEA, VerifyNow and VASP) and identified sharp cut points for HPR that were highly significant predictors of stent thrombosis and cardiovascular mortality [ 70 ].
← all excerpts
Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls.
1
—
—